A sex stratified outcome analysis from the OPEN-CTO registry.


Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
01 05 2019
Historique:
received: 13 07 2018
revised: 11 11 2018
accepted: 25 11 2018
pubmed: 21 12 2018
medline: 9 6 2020
entrez: 21 12 2018
Statut: ppublish

Résumé

Women have been under-represented in trials. Due to the dearth of information about CTO-PCI in women and discordance of previous results, sex differences in outcomes in the OPEN-CTO Trial were investigated. OPEN-CTO is an investigator-initiated, multicenter, prospective observational registry of consecutive CTO patients undergoing PCI at 12 U.S. centers. The one-year outcomes of this trial stratified by sex were examined. Optimal propensity matching was performed to compare outcomes between sexes. Multivariate conditional logistic regression modeling for predictors of procedural success was performed. Women represented 19.6% of the cohort (196/1,000 patients). Women were more likely to report dyspnea as their predominant symptom. Women reported statistically worse physical limitation and poorer quality of life as compared to men. J-CTO scores were similar in males and females. Technical, procedural success and MACE rates were similar in both sexes. Contrast and radiation doses were however significantly lower in women. The SAQ- summary score, RDS, EQ-5D VAS, PHQ-8 scores were all improved to the same degree at 1 year in women as compared to men. Predictors of procedural success revealed that younger age, lower J-CTO score and absence of prior CABG were predictors of procedural success. Sex did not predict procedural success or 1-year MACE in this regression model. This real-world registry revealed that women derive the same benefit from CTO-PCI as men without additional complications and with favorable health status outcomes at 1 year. Consideration of revascularization by PCI in symptomatic women should be considered as part of the treatment when appropriate.

Identifiants

pubmed: 30569618
doi: 10.1002/ccd.28023
doi:

Types de publication

Comparative Study Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1041-1047

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Ashish Pershad (A)

University of Arizona College of Medicine, Phoenix, Arizona.
Banner University Medical Center, Phoenix, Arizona.

Martha Gulati (M)

University of Arizona College of Medicine, Phoenix, Arizona.
Banner University Medical Center, Phoenix, Arizona.

Dimitrios Karmpaliotis (D)

Columbia University, New York Presbyterian Hospital, New York, New York.

Jeffery Moses (J)

Columbia University, New York Presbyterian Hospital, New York, New York.

William J Nicholson (WJ)

WellSpan Health, York, Pennsylvania.

Karen Nugent (K)

St. Lukes Mid America Heart Institute, Kansas City, Missouri.

Yuanyuan Tang (Y)

St. Lukes Mid America Heart Institute, Kansas City, Missouri.

James Sapontis (J)

Monash Heart, Melbourne, Victoria, Australia.

William Lombardi (W)

University of Washington, Seattle, Washington.

James A Grantham (JA)

St. Lukes Mid America Heart Institute, Kansas City, Missouri.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH